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We were delighted to read the study of 145 patients in Dublin
over seven years which compared CT and duplex ultrasound scan
surveillance for EVAR.1 In our unit we have adopted a similar ﬁrst
line surveillance programme using duplex ultrasound and abdom-
inal x-ray like yourselves. However, in addition, we have also
employed the use of contrast-enhanced ultrasound using micro-
bubble contrast in a subset of patients where endoleaks require
delineation or type deﬁnition as well as troubleshooting in cases
where we know there is sac size expansion in without endoleak
on CT. We have found contrast ultrasound particularly helpful as
have numerous groups in the literature for these selected patient
groups.2–5 The additional cost for adopting contrast-enhanced
ultrasound scan is minimal when compared with the price of tradi-
tionally performed CT surveillance programmes, which were tradi-
tionally performed.
We would like to ask the authors if they have used any micro-
bubble contrast for their surveillance? and if not why not? The
use of contrast-enhanced ultrasound would reduce the propor-
tion of additional scans required due to bowel gas or body
habitus. We have found the contrast microbubble reduces this
uncertainty. One other feature of your study which we felt we
would like explained were the actual costings and total periods
of clinical evaluation following endovascular stenting? We regu-
larly see our patients at six month or yearly intervals to see if
they are improving symptomatically and also to assess procedural
recovery. We have also found that if the patient is symptomatic,
then this correlates extremely well with unsatisfactory results
from stent-grafting. However, we are delighted with the results
you present and are in agreement in championing duplex ultra-
sound as the primary surveillance tool for patients who have
undergone endovascular aneurysm repair, but also recommend
the addition of contrast-enhanced ultrasound scan in selective
cases.References
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in Patients Younger than 60 Years’Dear Sir,
We were interested to read the retrospective study by Gupta
et al.1 which compared endovascular repair of abdominal aortic
aneurysm (AAA) with open repair in patients younger than 60 years
of age. Not surprisingly this constituted a small percentage of the
total number of AAA repairs performed within the 2007-9 NSQIP
data and as such is a unique cohort worthy of study.
By the very nature of the study design the authors were unable
to undertake a randomised approach or adequately match their
two comparison groups. As such they have opened their study to
considerable selection bias. Leaving patient allocation to EVAR orDOI of original article: 10.1016/j.ejvs.2012.02.006.
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varying risk proﬁles between the two groups with treatment choice
likely based on factors such as aneurysm size and patient co-
morbidities.
In their discussion, the authors go onto compare their study to
previous trials such as the EVAR1 and DREAM study. In order to
be included in the EVAR1 and DREAM trials, aneurysm size had
to be greater than 5.5 and 5 cm in size respectively.2,3 The present
study did not, however, have such strict inclusion criteria, with no
data on aneurysm size available.
We know that 30 day mortality rates were higher in both the
EVAR1 and DREAM trials than that of the current study, with the
authors putting this down to the older age of the patients and asso-
ciated increase in co-morbidities. However, without knowing the
aneurysm size of included patients we feel it would be unwise to
compare mortality outcomes between this study and previous
ones.
In conclusion, we feel that if we are to use a study as part of the
informed consent process for patients then these important issues
should be addressed.References
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